Event

Open to all scientists researching new therapeutics in Cambridge and the local area.

The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance.

 

Host: Babraham Institute

Date: Wednesday 18th November 2020, 18:00-19:45

Location: This event will take place online. Please register on Eventbrite and details will follow closer to the time.

 

Programme

 

18:00 – Welcome

18:10 – Dr Adrian Liston, Babraham Institute

Synthetic expansion of brain Tregs to prevent neuroinflammation

 

18:35 – Dr Sarah Ross, Babraham Institute

The impact of hypoxia on cytotoxic T cells: considerations for immunotherapies

 

18:50 – Dr Cassie Van Krinks, Kymab

KY1043 - a novel PD-L1 antibody-based IL-2 immunocytokine for the treatment

of advanced solid tumours

 

19:15 – Post-talk panel discussion with speakers (details to follow)

19:45 – Meeting close